Mitigate Unblinding Risks

Every clinical trial runs the risk of unintentional unblinding. With 30 years of experience designing reliable RTSM solutions and the processes behind it, Calyx IRT is the solution you can rely on to minimize these risks and ensure the integrity of your clinical trial.

The solution design and technical experts behind Calyx IRT have published a variety of resources to demonstrate where and how unblinding can occur and more importantly, how to minimize those risks.

Access them below!

TALK TO OUR IRT EXPERTS

博客

Untitled-14

最大程度降低数据相关的揭盲风险:您的问题已回答

Untitled-14

最大限度地降低随机分配期间的揭盲风险:您的问题已回答

16SEP2022-UnblindingBlog3_header2000x1000_V1

临床试验揭盲:它是什么,它不是什么

26AUG2022-unblindingblog2_header2000x1000_v1

临床试验如何意外揭盲

在临床试验中,一切都与盲人有关

获取最新消息

不错过任何精彩内容。立即注册,接收涵盖行业新闻和其他相关信息的电子邮件,帮助您推进临床开发。

  • 此字段用于验证目的,应保持不变。
Powered by Translations.com GlobalLink OneLink Software